Hyperliquid is consolidating its lead in on-chain derivatives, even as falling volumes elsewhere highlight the limits of incentive-driven growth.Markets, Hyperliquid, hype, NewsRead More

You might also be interested in reading Unapproved AI software being used to record doctor-patient meetings, investigation reveals.